Moderators should present facts for both sides. As for Aisling Capital, they exercised their series A warrants and sold, this is the mechanism for TRXC to raise funds to ramp up Senhance sales. This info has been in the public domain for the past 6 months.
Aisling Capital however also added 1M shares to their holdings and now holds over 11M shares, currently a 5% owner of TRXC. Aisling fund manager has deep connection to TRXC and hospitals, and if you want to follow big money, they would be a good bet, besides, Masters Capital 4M shares, and Sofar with 19M shares. Many big name funds still betting on TRXC, which I find quite unusual for $2 stock. Good day!
News 
Market Data 
Discover 
